Skip to main content
. Author manuscript; available in PMC: 2019 Jul 1.
Published in final edited form as: Clin Cancer Res. 2018 Mar 12;24(13):3053–3058. doi: 10.1158/1078-0432.CCR-17-1864

Figure 2:

Figure 2:

HER2 and p95HER2 vs. Number of Metastatic Sites. A, HER2 protein expression vs number of metastatic sites. B, p95HER2 protein expression versus number of metastatic sites. Measurements below the limit of detection are shown as < LOD. Abbreviations: HER2, human epidermal growth factor receptor 2; LOD, logarithm of odds.